We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

406 hedge funds and large institutions have $17.3B invested in Alexion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 406 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $149M | Put options by funds: $97.1M

Holders
406
Holders Change
+406
Holders Change %
–
% of All Funds
13.25%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
406
Increased
–
Reduced
–
Closed
–
Calls
$149M
Puts
$97.1M
Net Calls
+$51.9M
Net Calls Change
+$51.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LNB
376
Ledyard National Bank
$37K +$38.5K +400 New
TRCT
377
Tower Research Capital (TRC)
New York
$36K +$37.1K +385 New
LWCFA
378
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$32K +$33.7K +350 New
HNB
379
Huntington National Bank
Ohio
$31K +$32.8K +340 New
ECM
380
ETrade Capital Management
Virginia
$29K +$30.5K +316 New
JG
381
Jefferies Group
New York
$23K +$24.1K +250 New
CGT
382
Capital Guardian Trust
California
$20K +$20.7K +215 New
WT
383
Whittier Trust
California
$20K +$20.7K +215 New
RIA
384
Regal Investment Advisors
Michigan
$18K +$19.3K +200 New
JIC
385
Joel Isaacson & Co
New York
$17K +$17.3K +180 New
NES
386
New England Securities
New York
$17K +$17.4K +181 New
MCM
387
Manchester Capital Management
Vermont
$16K +$16.3K +169 New
OWP
388
Obermeyer Wealth Partners
Colorado
$14K +$14.5K +150 New
PTC
389
Private Trust Company
Ohio
$13K +$13.6K +141 New
RA
390
Rational Advisors
New York
$9K +$9.35K +97 New
AA
391
Apriem Advisors
California
$9K +$9.64K +100 New
FNBT
392
FineMark National Bank & Trust
Florida
$8K +$7.9K +82 New
FHA
393
First Horizon Advisors
Tennessee
$8K +$7.9K +82 New
AC
394
Alexandria Capital
Virginia
$8K +$8.19K +85 New
CTC
395
Central Trust Company
Missouri
$7K +$7.23K +75 New
WA
396
WFG Advisors
Texas
$7K +$7.32K +76 New
NIM
397
NuWave Investment Management
New Jersey
$6K +$6.07K +63 New
JFGIW
398
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$6K +$6.17K +64 New
DADC
399
D.A. Davidson & Co
Montana
$4K +$5.69K +59 New
PSUF
400
People's United Financial
Connecticut
$3K +$3.37K +35 New
13 14 15
16
17

ALXN Hedge Fund Activity: Q2 2013 in Review

406 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q2 2013, worth a combined $17.3B.

Buyers outnumbered sellers: 406 funds opened new ALXN positions and 0 closed out — a net gain of 406 holders — while 0 added to existing stakes and 0 trimmed.

  • 406 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.3B of Alexion Pharmaceuticals stock for Q2 2013.
  • 406 funds opened new Alexion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +406 holders.

Based on aggregated 13F filings for Q2 2013.